Latest Insider Transactions at Cano Health, Inc. (CANO)
This section provides a real-time view of insider transactions for Cano Health, Inc. (CANO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cano Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cano Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 16
2022
|
Solomon D Trujillo |
BUY
Grant, award, or other acquisition
|
Direct |
54,808
+24.75%
|
-
|
|
May 16
2022
|
Lewis Gold Director |
BUY
Grant, award, or other acquisition
|
Direct |
48,077
+11.7%
|
-
|
|
May 16
2022
|
Barry S Sternlicht Director |
BUY
Grant, award, or other acquisition
|
Direct |
48,077
+0.37%
|
-
|
|
May 09
2022
|
Brian D Koppy Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
40,484
-5.16%
|
$161,936
$4.38 P/Share
|
|
Mar 21
2022
|
Lewis Gold Director |
BUY
Conversion of derivative security
|
Indirect |
10,000
+0.8%
|
-
|
|
Mar 17
2022
|
Lewis Gold Director |
BUY
Open market or private purchase
|
Direct |
300,000
+48.79%
|
$1,800,000
$6.81 P/Share
|
|
Mar 15
2022
|
Mark Novell Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,783
+32.46%
|
-
|
|
Mar 15
2022
|
Brian D Koppy Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
181,280
+18.77%
|
-
|
|
Mar 15
2022
|
Richard Aguilar Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
171,641
+16.17%
|
-
|
|
Mar 15
2022
|
David J Armstrong |
BUY
Grant, award, or other acquisition
|
Direct |
125,474
+19.88%
|
-
|
|
Mar 15
2022
|
Marlow Hernandez |
BUY
Grant, award, or other acquisition
|
Direct |
624,418
+15.08%
|
-
|
|
Feb 07
2022
|
Lewis Gold Director |
BUY
Conversion of derivative security
|
Indirect |
1,381,935
+50.0%
|
-
|
|
Jan 28
2022
|
Elliot Cooperstone |
BUY
Grant, award, or other acquisition
|
Direct |
14,825
+50.0%
|
-
|
|
Jan 28
2022
|
Alan Muney |
BUY
Grant, award, or other acquisition
|
Direct |
14,825
+50.0%
|
-
|
|
Jan 28
2022
|
Lewis Gold Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,825
+50.0%
|
-
|
|
Jan 28
2022
|
Solomon D Trujillo |
BUY
Grant, award, or other acquisition
|
Direct |
14,825
+11.71%
|
-
|
|
Jan 28
2022
|
Barry S Sternlicht Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,825
+50.0%
|
-
|
|
Jan 28
2022
|
Angel L Morales |
BUY
Grant, award, or other acquisition
|
Direct |
14,825
+50.0%
|
-
|
|
Jan 28
2022
|
Kim M Rivera |
BUY
Grant, award, or other acquisition
|
Direct |
14,825
+50.0%
|
-
|
|
Jan 28
2022
|
Jacqueline Guichelaar Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,825
+50.0%
|
-
|
|
Jan 18
2022
|
Richard Aguilar Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+20.59%
|
-
|
|
Jan 18
2022
|
David J Armstrong |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+11.62%
|
-
|
|
Jan 13
2022
|
Brian D Koppy Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
373,972
+38.27%
|
-
|
|
Dec 22
2021
|
Richard Aguilar Chief Clinical Officer |
BUY
Other acquisition or disposition
|
Direct |
119,407
+18.39%
|
-
|
|
Dec 06
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
15,000
+0.52%
|
$120,000
$8.0 P/Share
|
|
Dec 03
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
12,500
+0.43%
|
$100,000
$8.75 P/Share
|
|
Nov 22
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
8,000
+0.28%
|
$72,000
$9.65 P/Share
|
|
Nov 18
2021
|
Solomon D Trujillo |
BUY
Open market or private purchase
|
Direct |
97,000
+50.0%
|
$970,000
$10.55 P/Share
|
|
Sep 21
2021
|
Mark Novell Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,023
+50.0%
|
-
|
|
Sep 21
2021
|
David J Armstrong |
BUY
Grant, award, or other acquisition
|
Direct |
285,333
+48.72%
|
-
|
|
Sep 21
2021
|
Richard Aguilar Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
285,333
+41.01%
|
-
|
|
Sep 21
2021
|
Brian D Koppy Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
190,000
+50.0%
|
-
|
|
Sep 21
2021
|
Marlow Hernandez |
BUY
Grant, award, or other acquisition
|
Direct |
1,339,500
+31.92%
|
-
|
|
Aug 31
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Indirect |
2,500
+3.57%
|
$27,500
$11.99 P/Share
|
|
Aug 31
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
5,833
+0.38%
|
$64,163
$11.99 P/Share
|
|
Aug 30
2021
|
Richard Aguilar Chief Clinical Officer |
BUY
Open market or private purchase
|
Direct |
1,749
+1.38%
|
$19,239
$11.93 P/Share
|
|
Aug 30
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
1,179,109
+22.7%
|
$12,970,199
$11.31 P/Share
|
|
Aug 30
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Indirect |
2,500
+3.7%
|
$27,500
$11.92 P/Share
|
|
Aug 27
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Indirect |
2,500
+3.84%
|
$27,500
$11.77 P/Share
|
|
Aug 27
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
5,833
+1.73%
|
$64,163
$11.84 P/Share
|
|
Aug 26
2021
|
Richard Aguilar Chief Clinical Officer |
BUY
Open market or private purchase
|
Direct |
72,013
+36.85%
|
$792,143
$11.99 P/Share
|
|
Aug 26
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Indirect |
6,240
+9.41%
|
$68,640
$11.62 P/Share
|
|
Aug 26
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
14,560
+4.27%
|
$160,160
$11.79 P/Share
|
|
Aug 25
2021
|
Richard Aguilar Chief Clinical Officer |
BUY
Open market or private purchase
|
Direct |
51,393
+50.0%
|
$565,323
$11.93 P/Share
|
|
Aug 25
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Indirect |
53,857
+50.0%
|
$592,427
$11.94 P/Share
|
|
Aug 25
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
54,727
+14.94%
|
$601,997
$11.93 P/Share
|
|
Aug 20
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
10,000
+3.75%
|
$100,000
$10.2 P/Share
|
|
Aug 19
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
25,000
+9.19%
|
$250,000
$10.38 P/Share
|
|
Aug 18
2021
|
Marlow Hernandez |
BUY
Open market or private purchase
|
Direct |
11,900
+5.09%
|
$107,100
$9.82 P/Share
|
|
Aug 18
2021
|
David J Armstrong |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
$150,000
$10.02 P/Share
|